聚多卡醇静脉内微泡沫在临床实践中的结果
本研究为前瞻性观察性研究,在两个静脉中心使用电子数据库收集数据,评估聚多卡醇静脉内微泡沫(PEM)治疗CEAP≥2级且有症状的浅静脉轴向反流患者的疗效,主要关注闭合率。共治疗60例患者,3个月和6个月闭合率均为93%,静脉临床严重程度评分(VCSS)从7.3改善至1.4。结论认为PEM安全有效,早期闭合率与非热非肿胀技术和热肿胀技术相当。
要点
- PEM治疗大隐静脉等浅静脉反流3个月和6个月闭合率均达93%。
- VCSS从术前平均7.3改善至1.4。
- 并发症包括深静脉血栓1例(1.7%)、血栓性浅静脉炎5例(8.3%)、皮肤色素沉着4例(6.6%)。
核心结论
- PEM对于治疗大隐静脉反流和静脉曲张是安全有效的。
- PEM的早期闭合率在6个月时得以维持,与非热非肿胀技术和热肿胀技术报告的结果相当。
研究设计与样本
- 前瞻性观察性研究,在两个静脉中心使用电子数据库前瞻性收集数据。
- 纳入CEAP分级≥2级且有症状的浅静脉轴向反流(大隐静脉、副大隐静脉、小隐静脉)患者,前瞻性随访。
- 共60例患者接受PEM治疗大隐静脉和静脉曲张。
主要发现
- CEAP分级:C2级32例,C3级14例,C4级10例,C5级4例。
- 术前平均VCSS为7.3,术后改善至1.4。
- 大隐静脉直径平均6.5 mm,长度平均31 cm,治疗所用PEM平均体积9.3 mL。
- 3个月闭合率为93%(54/58),6个月闭合率为93%(51/55)。
- 并发症:深静脉血栓1例(1.7%),血栓性浅静脉炎5例(8.3%),皮肤色素沉着4例(6.6%)。
临床怎么用
- PEM可用于CEAP≥2级有症状的浅静脉轴向反流患者的治疗,早期闭合率高。
- 治疗过程中需注意深静脉血栓、血栓性浅静脉炎和皮肤色素沉着等并发症的监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Initial phase III clinical studies with polidocanol endovenous microfoam (PEM) demonstrated its safety and efficacy in the treatment of superficial venous reflux. In those studies, the primary outcome requirement was to assess the improvement in symptoms related to superficial venous disease. The goal of the present study was to evaluate the efficacy of PEM technology in routine clinical practice-specifically, the closure rates after treatment. METHODS: We performed an observational study during which data were prospectively collected from 2 vein centers using an electronic database. Patients with CEAP (clinical, etiologic, anatomic, pathophysiologic) class ≥2 and symptomatic superficial axial reflux (great saphenous vein, anterior accessory saphenous vein, and small saphenous vein) were included and followed up prospectively. PEM was used to treat the saphenous vein and varicosities. The CEAP classification was used to classify chronic venous disease, and the venous clinical severity score (VCSS) was applied to measure the disease severity. Pain and discomfort were assessed using a visual analog scale, and the residual veins were assessed by physical examination. RESULTS: PEM was used to treat superficial reflux in 60 patients. The CEAP classification was C2 for 32 patients, C3 for 14, C4 for 10, and C5 for 4 patients. The average pretreatment VCSS was 7.3. The saphenous vein diameter was 6.5 mm, and the average length was 31 cm. The average volume of PEM used to treat the saphenous veins was 9.3 mL. The closure rate at 3 and 6 months was 93% (54 of 58) and 93% (51 of 55), respectively. The VCSS had improved from 7.3 to 1.4. Complications included 1 case of deep vein thrombosis (1.7%), 5 patients (8.3%) with thrombophlebitis, and 4 patients (6.6%) with skin pigmentation. CONCLUSIONS: PEM is safe and effective for the treatment of saphenous reflux and varicosities. The early closure rates using PEM were maintained at 6 months and are comparable to the results reported with nonthermal, nontumescent technologies and thermal tumescent technologies.
引用
- Kim PS, Elias S, Gasparis A, et al. Results of polidocanol endovenous microfoam in clinical practice. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32353594. doi:10.1016/j.jvsv.2020.04.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。